The Journal of Urology
Volume 172, Issue 5, Supplement , Pages S34-S37, November 2004

AN OVERVIEW OF CHEMOTHERAPY TRIALS IN LOCALIZED AND RECURRENT NONMETASTATIC PROSTATE CANCER

  • WILLIAM K. OH

      Affiliations

    • Corresponding Author InformationCorrespondence: Dana-Farber Cancer Institute, 44 Binney St., Boston, Massachusetts 02115 (telephone: 617-632-3466; FAX: 617-632-2165)
    • Corresponding Author InformationFinancial interest and/or other relationship with Aventis and Bristol Myers

From the Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0022-5347(05)61305-5

doi:10.1097/01.ju.0000141674.92253.fe

The Journal of Urology
Volume 172, Issue 5, Supplement , Pages S34-S37, November 2004

Article Tools